ArticleChembiochem : a European journal of chemical biology2025
A Tailored Phospho-p53 Library Probes Antibody Specificity and Recognition Limitations.
Article in Chembiochem : a European journal of chemical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The tumor suppressor protein p53, known as the "guardian of the genome," is regulated by a complex network of post-translational modifications. Phosphorylations at 7 Ser/Thr residues within the N-terminal transactivation domain 1 (TAD1) play a role in p53 activation, yet their precise mechanisms of action remain elusive due to challenges in accessing well-defined phosphorylated isoforms. To address this limitation, this study harnesses a recently developed approach for the semisynthesis of site-specifically phosphorylated p53 to generate a comprehensive library of singly phosphorylated p53 including all TAD1 sites: Ser6, Ser9, Ser15, Thr18, Ser20, Ser33, and Ser37. The library was then used to probe the specificity of common p53 antibodies in western blot analysis. This study's results confirm the specificity of the target site of most phosphorylation-specific anti-p53 antibodies, but also reveal wide-spread epitope masking by phosphorylation, which has implications for p53 research and diagnostics. This "designer" p53 library thus provides a toolkit to study the function of p53 phosphorylation directly and indirectly as a quality control agent for some of the most widely used reagents in the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.